AnalystsKostas BiliourisKostas Biliouris's Stock Forecasts
AnalystsKostas Biliouris
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4992 out of 5156 analysts
Average Return
-13.86%
Win Rate
34%18 out of 53
Risk vs Reward
Poor
Good
Kostas Biliouris's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avidity Biosciences IncRNA | +121.21% | $32.61 | $72.14 | 2025-03-11 - 2025-12-18 | Buy |
Alnylam Pharmaceuticals IncALNY | +74.37% | $154.39 | $269.21 | 2024-03-26 - 2025-03-26 | Buy |
Alnylam Pharmaceuticals IncALNY | +60.24% | $169.06 | $270.90 | 2023-10-09 - 2024-10-09 | Buy |
Verve Therapeutics IncVERV | +57.31% | $12.65 | $19.90 | 2022-06-16 - 2023-06-16 | Buy |
Centessa Pharmaceuticals PLCCNTA | +52.80% | $4.28 | $6.54 | 2022-08-10 - 2023-08-10 | Buy |
Kostas Biliouris Analyst Color
Get additional color on Kostas Biliouris's coverage of popular stocks
Kostas Biliouris's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Centessa Pharmaceuticals PLCCNTA | 7 | Buy | $62.00 | +149.50% | Maintains | 9 days ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $50.00 | +145.82% | Upgrades | 3 months ago |
Tourmaline Bio IncTRML | 1 | Hold | $48.00 | +0.04% | Downgrades | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 6 | Buy | $470.00 | +18.67% | Maintains | 3 months ago |
Ionis Pharmaceuticals IncIONS | 3 | Buy | $70.00 | -9.83% | Upgrades | 4 months ago |
Jasper Therapeutics IncJSPR | 1 | Hold | $4.00 | +115.05% | Downgrades | 5 months ago |
Verve Therapeutics IncVERV | 3 | Hold | $13.50 | +21.29% | Downgrades | 6 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $8.00 | +147.68% | Maintains | 7 months ago |
Avidity Biosciences IncRNA | 1 | Buy | $72.00 | -0.19% | Initiates Coverage On | 9 months ago |
Dyne Therapeutics IncDYN | 1 | Buy | $50.00 | +169.54% | Initiates Coverage On | 9 months ago |
Silence Therapeutics PLCSLN | 2 | Buy | $25.00 | +301.28% | Maintains | 10 months ago |
Intellia Therapeutics IncNTLA | 6 | Buy | $50.00 | +463.06% | Maintains | a year ago |
Precision Biosciences IncDTIL | 3 | Buy | $34.00 | +652.21% | Upgrades | a year ago |
Metagenomi IncMGX | 2 | Buy | $17.00 | N/A | Maintains | a year ago |
4d Molecular Therapeutics IncFDMT | 4 | Buy | $40.00 | N/A | Maintains | a year ago |
Legend Biotech CorpLEGN | 3 | Buy | $90.00 | N/A | Maintains | a year ago |
Korro Bio IncKRRO | 3 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Buy | $57.00 | N/A | Maintains | 2 years ago |
Bridgebio Pharma IncBBIO | 1 | Hold | $37.00 | N/A | Initiates Coverage On | 2 years ago |
Biomarin Pharmaceutical IncBMRN | 4 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Prime Medicine IncPRME | 1 | Buy | $19.00 | N/A | Initiates Coverage On | 2 years ago |
Lenz Therapeutics IncLENZ | 2 | Hold | $7.00 | N/A | Downgrades | 3 years ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $98.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.